Author: Office Manager
Pharmacy Times | FDA Grants Fast Track Designation to STRO-002 for Advanced Ovarian Cancer

STRO-002 is a folate receptor alpha-targeting antibody drug conjugate for the treatment of patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received 1 to 3 prior lines of systemic therapy. Sutro Biopharma has been granted FDA Fast Track Designation for STRO-002, a folate receptor alpha-targeting antibody drug conjugate indicated for […]

Healio | FDA grants fast track designation to STRO-002 for advanced gynecologic cancers

The FDA granted fast track designation to STRO-002 for treatment of certain women with advanced gynecologic cancer. The designation applies to use of the agent with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer who received one to three prior lines of systemic therapy.

Cell and Gene Therapy | State-of-the-Art GMP Manufacturing RNA Cell Therapies With Cartesian’s CEO

Dr. Murat Kalayoglu, CEO at Cartesian Therapeutics, details the cell and gene therapy sector’s advancements in RNA cell therapy and the why behind the company’s decision to build its own wholly-owned GMP manufacturing facility.